Home
Register for Updates
Contact Us
NASDAQ:
32.33
-
0.21
-
0.65%
Volume:
114,490
June 19, 2013
Who We Are
Overview
Message from CEO
Leadership
Board of Directors
Contact Us
What We Do
Portfolio
Business Model
Major Assets
Collaborations
GlaxoSmithKline
Onyx
Merck
Bristol-Myers Squibb
Pfizer
Exelixis
Chiva Pharmaceuticals
Baxter
The Medicines Company
SAGE
Lundbeck
Retrophin
Spectrum
MEI Pharma
Sanofi
Rib-X
Royalty Table
Licensing Opportunities
Fablyn
SARM
Diabetes Portfolio
EPO/GCSF
IV Topiramate
LGD-313
LGD-461
LGD-3437
CRTH2 Antagonist
Contact Business Development
Captisol
News
News
Events
Investors
Investor Overview
News & Events
Press Releases
Investor Calendar
Webcasts & Presentations
Analyst Coverage
SEC Filings
Stock Information
Stock Quote
Stock Chart
Price Lookup
Corporate Governance
Email Alerts
Contact Us
RSS Feeds
E-mail Page
|
RSS Feeds
|
E-mail Alerts
|
Financial Tear Sheet
Terms of Use
Site Map
Powered By Q4 Web Systems
3.8.2.5449